MPS1 is overexpressed in different cancer types, including breast cancer, hepatocellular carcinoma, pancreatic cancer, gastric cancer, and endometrial cancer, and is correlated with poor patient prognosis [23,24,25,26]. Here, TTK is linked to hepatocellular carcinoma.